Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -69.35% is in line with its 1-year average of -71.32%, around the middle of its 1-year range (-139.89%–-36.43%).
As of the fiscal period ended Tuesday, June 30, 2026. 1.11% below its 12-month average of -68.59%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -69.35%.
RETURN ON INVESTED CAPITAL (ROIC)
-69.35%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-68.59%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-1.11%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
-94.56%
vs the sector median at left
MapLight Therapeutics, Inc.
Market Cap
$412.06M
Return on Invested Capital (ROIC)
-69.35%
TTM Avg
-68.59%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$411.43M
Return on Invested Capital (ROIC)
-7.11%
TTM Avg
-10.90%
3Y Avg
-16.50%
5Y Avg
-14.69%
Market Cap
$409.37M
Return on Invested Capital (ROIC)
-81.80%
TTM Avg
-65.32%
3Y Avg
-58.77%
5Y Avg
-53.22%
Market Cap
$407.12M
Return on Invested Capital (ROIC)
-46.16%
TTM Avg
-62.80%
3Y Avg
-62.80%
5Y Avg
-62.80%
Market Cap
$417.56M
Return on Invested Capital (ROIC)
-71.22%
TTM Avg
-79.15%
3Y Avg
-65.81%
5Y Avg
-107.73%
Market Cap
$406.25M
Return on Invested Capital (ROIC)
-89.93%
TTM Avg
-54.36%
3Y Avg
-39.52%
5Y Avg
-23.86%
Market Cap
$404.71M
Return on Invested Capital (ROIC)
-19.13%
TTM Avg
-11.02%
3Y Avg
-12.07%
5Y Avg
-13.96%
Market Cap
$419.61M
Return on Invested Capital (ROIC)
-21.36%
TTM Avg
-47.45%
3Y Avg
-35.84%
5Y Avg
-28.07%
Market Cap
$417.71M
Return on Invested Capital (ROIC)
-48.61%
TTM Avg
-80.33%
3Y Avg
-62.04%
5Y Avg
-50.84%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MapLight Therapeutics, Inc. (MPLT) | $412.06M | -69.35% | -68.59% | N/A | N/A |
| Strata Critical Medical, Inc. (SRTA)vs › | $411.43M | -7.11% | -10.90% | -16.50% | -14.69% |
| Rezolute, Inc. (RZLT)vs › | $409.37M | -81.80% | -65.32% | -58.77% | -53.22% |
| Eikon Therapeutics, Inc. Common Stock (EIKN)vs › | $407.12M | -46.16% | -62.80% | -62.80% | -62.80% |
| Senseonics Holdings, Inc. (SENS)vs › | $417.56M | -71.22% | -79.15% | -65.81% | -107.73% |
| Atea Pharmaceuticals, Inc. (AVIR)vs › | $406.25M | -89.93% | -54.36% | -39.52% | -23.86% |
| Myriad Genetics, Inc. (MYGN)vs › | $404.71M | -19.13% | -11.02% | -12.07% | -13.96% |
| Prothena Corporation plc (PRTA)vs › | $419.61M | -21.36% | -47.45% | -35.84% | -28.07% |
| Editas Medicine, Inc. (EDIT)vs › | $417.71M | -48.61% | -80.33% | -62.04% | -50.84% |
| ARS Pharmaceuticals, Inc. (SPRY)vs › | $422.54M | -114.65% | -31.55% | -26.30% | -23.63% |
ROIC
-69.4%
ROE
-66.0%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -69.35% |
| 2026-03-31 | -51.81% |
| 2025-12-31 | -36.43% |
| 2025-09-30 | -45.45% |
| 2025-06-30 | -139.89% |
| 2025-03-31 | -87.73% |
| 2024-12-31 | -68.55% |
